Encompass Health Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 1.05 B

Encompass Health Corporation Operating Cash Flow is USD 1.05 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 22.15% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Encompass Health Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 861.70 M, a 20.55% change year over year.
  • Encompass Health Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 714.80 M, a -7.91% change year over year.
  • Encompass Health Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 776.20 M, a -6.92% change year over year.
  • Encompass Health Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 833.90 M, a 65.23% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities